The Future Is Fluid
Liquid Biopsy Has Proven Its Mettle in the Fight against NSCLC and May Soon Also Be Standard of Care in Other Cancers
Genomics Brings Heavy Lifting to Immuno-Oncology
The Synergy of Two Burgeoning Fields Will Lead to Improved Precision Medicine
Singling Out RNA Biomarkers in Situ
ACD’s ISH Platform Achieves Single-Base Resolution and Retains Morphological Context
Microanalyte MDx Goes Mainstream
Nucleic Acid Analytes Are Reliable Sources of Data for Diagnostic Calculations
Limiting Noninvasive Prenatal Testing
A new report on noninvasive prenatal testing (NIPT) by the UK's Nuffield Council on Bioethics expresses concerns about the way the test is being sold by private providers. In addition, the Council calls for better information and support, a moratorium on the use of NIPT in sequencing the whole genome of fetuses and a ban on its use in finding out the sex of the fetus.
The Council considered, at this early stage of its use, how NIPT could change the way we view pregnancy, disability, and difference, and what the wider consequences of its increasing use might be. The report recommends that NIPT should only be used for significant medical conditions and impairments that affect the child at birth or in early life, as this information can allow women and couples to make meaningful reproductive choices.